SWOG clinical trial number
SWOG-434

Imidazole Carboxamide Dimethyl Triazene (NSC-45388) in Patients with Solid Tumors (Excluding Melanomas, Lymphomas, and Breast Cancer)

Closed
Phase
Accrual
58%
Abbreviated Title
Imidazole Carboxamide Dimethyl Triazene (NSC-45388) in Patients with Solid Tumors (Excluding Melanomas, Lymphomas, and Breast Cancer)
Activated
05/20/1969
Closed
06/24/1970

Publication Information Expand/Collapse

2014

A phase II trial of BAY 43-9006 (Sorafenib) (NSC-724772) in patients with relapsing and resistant multiple myeloma: SWOG S0434

G Srkalovic;M Hussein;A Hoering;J Zonder;L Popplewell;H Trivedi;S Mazzoni;R Sexton;R Orlowski;B Barlogie Cancer Medicine 3(5):1275-1283;

PMid: PMID24913924 | PMC number: PMC4302677

2009

A phase II trial of sorafenib in patients with relapsing and resistant multiple myeloma (MM) previously treated with bortezomib (S0434)

G Srkalovic;M Hussein;V Bolejack;A Hoering;JA Zonder;B Barlogie Journal of Clinical Oncology 27:15s, abst. #e19517